DGAP-News: Sangui BioTech International Inc.: - Sales of USD 18,560 in first quarter - Reduction of the operating loss

Hamburg, November 15, 2021: In the first three months of fiscal year 2022 (to 30/06/2022) Sangui BioTech International Inc. achieved revenues from royalty income of USD 18,560.